Harte-Hanks, Inc. (HHS) Reports In-Line Q2 EPS, Revenue Beat Expectations
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $6.98 --0%
Revenue Growth %: -0.7%
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: -0.7%
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Harte-Hanks, Inc. (NYSE: HHS) reported Q2 adjusted EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter came in at $213 million versus the consensus estimate of $208.98 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- STMicroelectronics N.V. (STM) Misses Q1 EPS by 9c; offers Q2 outlook
- Ford (F) earnings top estimates in Q1 amid strength in Pro unit; stock up
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
